Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
NCT04002934
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG:
Bazedoxifene Acetate
Sponsor
Riley Bove, MD